多发性硬化症表现为独立于复发活动的进行性视觉损伤:一例报告

Shun Akaike , Tomoko Okamoto , Ariko Miyazawa , Yuji Takahashi
{"title":"多发性硬化症表现为独立于复发活动的进行性视觉损伤:一例报告","authors":"Shun Akaike ,&nbsp;Tomoko Okamoto ,&nbsp;Ariko Miyazawa ,&nbsp;Yuji Takahashi","doi":"10.1016/j.nerep.2023.100172","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Visual impairment due to optic neuritis is one of the most common manifestations of multiple sclerosis (MS); however progressive visual loss without relapse is rare. Furthermore, the association of progression independent of relapse activity (PIRA) with visual impairment has not been largely explored. We report a rare case of MS associated with progressive visual loss, independent of relapse, with detailed follow-up data of visual acuity, critical flicker fusion frequency (CFF), and visual-evoked potential (VEP), which provided supporting evidence for monitoring visual function.</p></div><div><h3>Case report</h3><p>A 44-year-old Japanese woman with MS presented with decreased visual acuity in both eyes. Her symptoms progressed slowly without relapse and did not respond to intravenous methylprednisolone or plasma exchange. Her CFF and VEP also showed gradual exacerbation. Magnetic resonance imaging revealed no new lesions of MS. Visual impairment was correlated with physical worsening, suggesting progression independent of relapse. After ofatumumab was initiated, her visual acuity mildly improved.</p></div><div><h3>Conclusion</h3><p>We describe a patient with visual impairment that was considered the PIRA. Impairment of visual function, in addition to impaired walking ability and cognitive function, should be considered when assessing disability progression in MS. CFF and P100 latency of VEP may aid in the early diagnosis of PIRA, potentially leading to timely treatment.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"3 ","pages":"Article 100172"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Multiple sclerosis presenting with progressive visual impairment independent of relapse activity: A case report\",\"authors\":\"Shun Akaike ,&nbsp;Tomoko Okamoto ,&nbsp;Ariko Miyazawa ,&nbsp;Yuji Takahashi\",\"doi\":\"10.1016/j.nerep.2023.100172\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Visual impairment due to optic neuritis is one of the most common manifestations of multiple sclerosis (MS); however progressive visual loss without relapse is rare. Furthermore, the association of progression independent of relapse activity (PIRA) with visual impairment has not been largely explored. We report a rare case of MS associated with progressive visual loss, independent of relapse, with detailed follow-up data of visual acuity, critical flicker fusion frequency (CFF), and visual-evoked potential (VEP), which provided supporting evidence for monitoring visual function.</p></div><div><h3>Case report</h3><p>A 44-year-old Japanese woman with MS presented with decreased visual acuity in both eyes. Her symptoms progressed slowly without relapse and did not respond to intravenous methylprednisolone or plasma exchange. Her CFF and VEP also showed gradual exacerbation. Magnetic resonance imaging revealed no new lesions of MS. Visual impairment was correlated with physical worsening, suggesting progression independent of relapse. After ofatumumab was initiated, her visual acuity mildly improved.</p></div><div><h3>Conclusion</h3><p>We describe a patient with visual impairment that was considered the PIRA. Impairment of visual function, in addition to impaired walking ability and cognitive function, should be considered when assessing disability progression in MS. CFF and P100 latency of VEP may aid in the early diagnosis of PIRA, potentially leading to timely treatment.</p></div>\",\"PeriodicalId\":100950,\"journal\":{\"name\":\"Neuroimmunology Reports\",\"volume\":\"3 \",\"pages\":\"Article 100172\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimmunology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667257X23000104\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimmunology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667257X23000104","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

引言视神经炎引起的视觉损伤是多发性硬化症(MS)最常见的表现之一;然而,进行性视力丧失而不复发是罕见的。此外,独立于复发活动的进展(PIRA)与视觉障碍的关系尚未得到广泛探讨。我们报告了一例罕见的多发性硬化症伴进行性视力丧失,与复发无关,并提供了视力、临界闪烁融合频率(CFF)和视觉诱发电位(VEP)的详细随访数据,为监测视觉功能提供了支持性证据。病例报告一位44岁的日本女性多发性硬化症患者双眼视力下降。她的症状进展缓慢,没有复发,对静脉注射甲基强的松龙或血浆置换没有反应。她的CFF和VEP也逐渐恶化。磁共振成像显示MS没有新的病变。视觉障碍与身体状况恶化相关,表明进展与复发无关。奥法图单抗使用后,她的视力略有改善。结论我们描述了一名视觉障碍患者,该患者被认为是PIRA。在评估多发性硬化症的残疾进展时,除了行走能力和认知功能受损外,还应考虑视觉功能受损。CFF和VEP的P100潜伏期可能有助于PIRA的早期诊断,有可能导致及时治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Multiple sclerosis presenting with progressive visual impairment independent of relapse activity: A case report

Introduction

Visual impairment due to optic neuritis is one of the most common manifestations of multiple sclerosis (MS); however progressive visual loss without relapse is rare. Furthermore, the association of progression independent of relapse activity (PIRA) with visual impairment has not been largely explored. We report a rare case of MS associated with progressive visual loss, independent of relapse, with detailed follow-up data of visual acuity, critical flicker fusion frequency (CFF), and visual-evoked potential (VEP), which provided supporting evidence for monitoring visual function.

Case report

A 44-year-old Japanese woman with MS presented with decreased visual acuity in both eyes. Her symptoms progressed slowly without relapse and did not respond to intravenous methylprednisolone or plasma exchange. Her CFF and VEP also showed gradual exacerbation. Magnetic resonance imaging revealed no new lesions of MS. Visual impairment was correlated with physical worsening, suggesting progression independent of relapse. After ofatumumab was initiated, her visual acuity mildly improved.

Conclusion

We describe a patient with visual impairment that was considered the PIRA. Impairment of visual function, in addition to impaired walking ability and cognitive function, should be considered when assessing disability progression in MS. CFF and P100 latency of VEP may aid in the early diagnosis of PIRA, potentially leading to timely treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信